CASI Pharmaceuticals financials at a glance

+ Portfolio

The revenue of CASI Pharmaceuticals is reported as 0.03388 billion Dollars in the fiscal year 2023. The earnings were -1.82 Dollars per share in 2023, which was 34.06 higher than 2020. And about -0.02177 billion Dollars are reported as free cash flow in the financials of CASI Pharmaceuticals 2023. No dividends were paid to the shareholders of the CASI Pharmaceuticals stock NasdaqCM:CASI in the financial year 2023.

$33.88M

Revenue

$-1.82

Earnings Per Share

59.19%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

33.88

Earnings Per Share

-1.82

Gross Margin %

59.19

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2020	2019	2018	2017	2016	2015	2014	2010	2007	2006	2005	2004
Rev.	Revenue	N/A	$33.88M	$15.14M	$4.13M	$0.00M	$0.00M	$0.00M	$0.05M	$0.00M	$0.00M	$7.40M	$6.89M	$5.92M	$0.51M
GM %	Gross Margin %	63.84%	59.19%	37.20%	4.74%	0.00%	0.00%	0.00%	86.85%	68.53%	100.00%	100.00%	100.00%	100.00%	100.00%
OM	Operating Margin	-63.70%	-74.62%	-,220.02%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-,122.78%	0.00%	0.00%	-,292.79%	0.00%
EPS	Earnings Per Share	$-3.02	$-1.82	$-2.76	$-4.07	$-3.16	$-1.80	$-1.70	$-2.20	$-9.20	$-9.40	$-30.80	$-78.11	$-39.60	$-40.70
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	12.99M	13.98M	9.9M	9.57M	6.98M	6.02M	3.24M	3.24M	1.14M	0.78M	0.77M	0.58M	0.39M
OCF	Operating Cash Flow	N/A	$0.00M	$-25.89M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$-27.39M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$0.00	$-1.66	$-3.85	$-3.88	$-5.94	$-1.19	$-1.12	$-1.71	$-1.56	$-5.13	$-30.88	$-32.14	$-33.72	$-49.08

CASI Pharmaceuticals financials at a glance

Financials

Discover